Recordings Now Available: Supporting People with Advanced Cancer – A BOPA, UKONS and Prostate Cancer UK Joint Webinar

The recent BOPA E&T Webinar Session on Supporting People with Advanced Cancer is now available to view on the BOPA website HERE.

The recording of this joint webinar by BOPA, UKONS and Prostate Cancer is available to watch for all paid members and free associates at any time.

 

E&T Webinar Series from 2021 onwards are now available as eLearnings under the Education Section on the BOPA website: https://www.bopa.org.uk/courses/

All BOPA Webinars can also be found under the Resources Section on the website, filtered under webinars (https://www.bopa.org.uk/resources/?_sft_resource-type=webinar)

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article